ProteinQure: Funding, Investors & Team (Sep 2026)
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical purposes. Using advanced technology and artificial intelligence, we develop dynamic peptides that deliver drugs directly to their target, surpassing other methods of drug delivery. By breaking new ground in therapeutics, we are revolutionizing drug development and providing hope to patients with previously incurable illnesses. Our team at ProteinQure is made up of experts in experimental and computational biology, machine learning, and software engineering, bringing together a diverse range of skills and knowledge.
ProteinQure has raised $12.8M across 2 funding rounds on record, the most recent an undisclosed round of $1.8M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ProteinQure Company Profile and Key Stats
Latest funding round on record: May 2026.
ProteinQure Funding Rounds
ProteinQure raised $11.0M in a Series A announced in May 2025.
1 years later, an undisclosed round of $1.8M was announced in May 2026.
ProteinQure Founders and Leadership Team
No contact details are on record for this team yet.
ProteinQure Funding Compared to Other Biotechnology Startups
ProteinQure's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ProteinQure in Biotechnology and Toronto
Companies Similar to ProteinQure
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Resverlogix Corporation, a biopharmaceutical company, focuses on the development of novel therapeutics in…
ProteinQure Funding FAQs
What does ProteinQure do?
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical purposes. Using advanced technology and artificial intelligence, we develop dynamic peptides that deliver drugs directly to their target, surpassing other methods of drug delivery. By breaking new ground in therapeutics, we are revolutionizing drug development and providing hope to patients with previously incurable illnesses. Our team at ProteinQure is made up of experts in experimental and computational biology, machine learning, and software engineering, bringing together a diverse range of skills and knowledge.
How much funding has ProteinQure raised?
ProteinQure has raised $12.8M across 2 rounds on record. The most recent is an undisclosed round of $1.8M announced in May 2026.
When did ProteinQure last raise funding?
ProteinQure's most recent funding round on record is an undisclosed round of $1.8M, announced in May 2026.
Who founded ProteinQure?
FundedIQ lists Lucas Siow (Founder) at ProteinQure.
Where is ProteinQure headquartered?
ProteinQure is based in Toronto, Ontario, Canada.
How many employees does ProteinQure have?
ProteinQure is in the 11-50 employee band.
How does ProteinQure's funding compare to other Biotechnology startups?
ProteinQure's latest round of $1.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ProteinQure Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ProteinQure is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.